ArticleClinical epigenetics2026

Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy.

Dorian Pamart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.